Inicio › Cáncer (todos los tipos) › Washington › Seattle
Ensayos clínicos de Cáncer (todos los tipos) en Seattle, WA
48 estudios para Cáncer (todos los tipos) buscan participantes en centros de Seattle y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
ReclutandoFase 1
- Fred Hutchinson Cancer Center - Seattle - Eastlake Avenue East /ID# 267940, Seattle
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
ReclutandoFase 2
- Seattle Neuropsychiatric Treatment Center, Seattle
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
ReclutandoFase 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- y 4 más
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
ReclutandoFase 1
- Swedish Cancer Institute, Seattle
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- Swedish Medical Center, Seattle
- VA Puget Sound Health Care System, Seattle
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
ReclutandoFase 2/3
- Local Institution - 01257, Seattle
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
ReclutandoFase 2
- Seattle Children's Hospital, Seattle
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
ReclutandoFase 1
- Fred Hutchinson Cancer Research Center, Seattle
Collection of Tissue Samples for Cancer Research
ReclutandoEstudio observacional
- Fred Hutchinson, Seattle
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
ReclutandoEstudio observacional
- Fred Hutchinson Cancer Center, Seattle
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
ReclutandoFase 2
- Seattle Children's Hospital, Seattle
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
ReclutandoFase 3
- Fred Hutchinson Cancer Center ( Site 0106), Seattle
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
ReclutandoFase 2/3
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Suprachoroidal Administration in Subjects With Metastases to the Choroid
ReclutandoFase 2
- University of Washington, Seattle
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
ReclutandoFase 1/2
- University of Washington Medical Center, Seattle
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
ReclutandoFase 2/3
- University of Washington Medical Center /ID# 275866, Seattle
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
ReclutandoFase 2/3
- Fred Hutchinson Cancer Center. /ID# 277939, Seattle
Registry Study for Radiation Therapy Outcomes
ReclutandoEstudio observacional
- University of Washington, Seattle
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
Reclutando
- Seattle Children's Hospital, Seattle
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ReclutandoFase 2
- Swedish Cancer Institute, Seattle
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ReclutandoFase 1
- Fred Hutchinson Cancer Center, Seattle
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
ReclutandoEstudio observacional
- University of Washington, Seattle
Prostate Active Surveillance Study
ReclutandoEstudio observacional
- Veterans Affairs Puget Sound Health Care System, Seattle
- University of Washington, Seattle
Project: Every Child for Younger Patients With Cancer
ReclutandoEstudio observacional
- Seattle Children's Hospital, Seattle
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
ReclutandoFase 1/2
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
ReclutandoSe aceptan voluntarios sanos
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
ReclutandoFase 1
- Fred Hutchinson Cancer Center, Seattle
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
ReclutandoFase 2
- Seattle Children's Hospital Research Foundation, Seattle
Resilience Mobile App for Teens and Young Adults With Cancer
Reclutando
- Seattle Children's Hospital, Seattle
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
ReclutandoFase 1
- GSK Investigational Site, Seattle
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Reclutando
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Childhood Cancer Survivor Study
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Seattle Children's Hospital, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
ReclutandoFase 1/2
- Fred Hutchinson Cancer Center, Seattle
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
ReclutandoFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
ReclutandoFase 2Se aceptan voluntarios sanos
- Fred Hutchinson Cancer Centre, Seattle
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
ReclutandoFase 1
- Fred Hutchinson Cancer Center, Seattle
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
ReclutandoEstudio observacional
- Seattle Children's Hospital, Seattle
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
ReclutandoFase 2
- Swedish Cancer Institute, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Seattle
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
ReclutandoFase 1
- Fred Hutch Cancer Center, Seattle
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
ReclutandoEstudio observacional
- The Swedish Hospital, Seattle
A Study of NX-1607 in Adults With Advanced Malignancies
ReclutandoFase 1
- Fred Hutchinson Cancer Center, Seattle
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
ReclutandoFase 1/2
- Fred Hutch Cancer Center, Seattle
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
ReclutandoEstudio observacional
- Swedish Cancer Institute, Seattle
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
ReclutandoEstudio observacional
- University of Washington / Fred Hutchinson Cancer Center, Seattle
A Crowd Sourcing Platform for Patients With Cancer
ReclutandoEstudio observacional
- All4Cure, Seattle
AIMS Cancer Outcomes Study
ReclutandoEstudio observacional
- AIMS Institute, Seattle
Más información sobre Cáncer (todos los tipos) en MedlinePlus
Ensayos de Cáncer (todos los tipos) en otras ciudades
- Houston, TX124 estudios
- New York City, NY105 estudios
- Boston, MA90 estudios
- Los Angeles, CA73 estudios
- Nashville, TN65 estudios
- Durham, NC61 estudios
- Washington, DC60 estudios
- Philadelphia, PA57 estudios
- Arlington, VA52 estudios
- Chicago, IL51 estudios
- St. Louis, MO51 estudios
- Atlanta, GA49 estudios
Otros estudios en Seattle
- Cáncer de pulmón de células no pequeñas55 estudios
- Cáncer de próstata45 estudios
- Leucemia mielógena aguda40 estudios
- Cáncer metastásico39 estudios
- Cáncer de seno37 estudios
- Cáncer del colon y del recto35 estudios
- Cáncer de pulmón34 estudios
- Cáncer de ovario29 estudios
- Cáncer de páncreas22 estudios
- Mieloma múltiple22 estudios
- Leucemia linfoblástica aguda22 estudios
- Leucemia linfocítica crónica22 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.